AEON (STOCKS)
AEON Biopharma, Inc.
$0.870000
+0.030000 (+3.57%)
Prev close: $0.840000
Company Information
- Exchange
- XASE
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Robert E. Bancroft
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $20.91M
- Employees
- 5
- P/E (TTM)
- -0.47
- P/B (TTM)
- -0.18
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.42 | $-0.13 | -0.2925 | -229.41% |
|
Sep 2025 (Q3)
|
$-0.19 | $-0.44 | +0.2486 | +56.68% |
|
Jun 2025 (Q2)
|
$-0.38 | $-0.36 | -0.0230 | -6.44% |
|
Sep 2024 (Q3)
|
$-6.48 | $-11.75 | +5.2704 | +44.85% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$26.42M |
| Operating Expenses | $12.80M |
| Selling, General, and Administrative Expenses | $12.21M |
| Research and Development | $4.09M |
| Operating Income/Loss | -$12.80M |
| Income/Loss From Continuing Operations After Tax | -$39.22M |
| Income/Loss From Continuing Operations Before Tax | -$39.22M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$39.22M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$39.22M |
| Net Income/Loss Available To Common Stockholders, Basic | -$39.22M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.95 |
| Diluted Earnings Per Share | -$3.95 |
| Basic Average Shares | 9,921,587 |
| Diluted Average Shares | 9,921,587 |
| Assets | $5.56M |
| Current Assets | $3.40M |
| Noncurrent Assets | $2.16M |
| Fixed Assets | $162.00K |
| Other Non-current Assets | $2.00M |
| Liabilities | $60.59M |
| Current Liabilities | $6.90M |
| Accounts Payable | $942.00K |
| Wages | $2.87M |
| Other Current Liabilities | $3.08M |
| Noncurrent Liabilities | $53.69M |
| Equity | -$55.03M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$55.03M |
| Liabilities And Equity | $5.56M |
| Net Cash Flow From Operating Activities | -$17.31M |
| Net Cash Flow From Operating Activities, Continuing | -$17.31M |
| Net Cash Flow From Investing Activities | -$4.00K |
| Net Cash Flow From Investing Activities, Continuing | -$4.00K |
| Net Cash Flow From Financing Activities | $20.31M |
| Net Cash Flow From Financing Activities, Continuing | $20.31M |
| Net Cash Flow | $2.99M |
| Net Cash Flow, Continuing | $2.99M |
| Comprehensive Income/Loss | -$39.22M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$39.22M |
| Other Comprehensive Income/Loss | $0.00 |